Post-marketing surveillance data continues to accumulate as Zepbound use expands in real-world clinical practice
Antioxidants (2021) 10:1179
COMPOUNDED LIRAGLUTIDE BENEFITS Do more, age less Contains Liraglutide as the primary active ingredient Daily GLP-1 injectable for continuous appetite regulation and blood sugar control Targets the GLP-1 hormone receptors to reduce appetite and cravings Liraglutide mimics the natural GLP-1 hormone, which plays a key role in blood sugar and appetite control Clinical trials show patients lose between 5-10% body weight Use with reduced-calorie meal plan and exercise for best results * Compounded Liraglutide has not been reviewed or approved by the FDA or analyzed by any available scientific study
These numbers represent the largest weight-loss magnitudes recorded in randomized phase 3 trials for this class of medication, approaching the efficacy historical patterns seen with surgical interventions like sleeve gastrectomy
Legislation In Nevada, Governor Lombardo signed SB 494, which established the Nevada Health Authority, a new agency that will assume some of the functions of the states Department of Health and Human Services, including tracking prescription drug costs and managing Medicaid
